Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial

Background: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in paediatric Japanese patients aged between 1 and 15 years. Methods: In this multi-centre, ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Kimihiro, Inoue, Yoichi, Numaguchi, Hirotaka, Tanaka, Kumi, Saito, Itori, Oshima, Nobuyuki, Matsumoto, Yuki, Prohn, Marita, Mehta, Anish, Nishida, Chisato, Philip, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040008/
https://www.ncbi.nlm.nih.gov/pubmed/27785374
http://dx.doi.org/10.1080/21556660.2016.1209507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040008/
https://www.ncbi.nlm.nih.gov/pubmed/27785374
http://dx.doi.org/10.1080/21556660.2016.1209507

Ejemplares similares